HER2-positive gastric cancer

Por Boku, Narikazu
Publicado em 2013

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508

Por Kurokawa, Yukinori, Muto, Manabu, Minashi, Keiko, Boku, Narikazu, Fukuda, Haruhiko
Publicado em 2009

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

Por Boku, Narikazu, Muro, Kei, Machida, Nozomu, Hashigaki, Satoshi, Kimura, Nobuyuki, Suzuki, Mie, Lechuga, Mariajose, Miyata, Yoshinori
Publicado em 2013

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

Por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado no Cancer Sci (2014)

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

Por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado no Cancer Sci (2015)

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer

Por Doi, Toshihiko, Yoshino, Takayuki, Fuse, Nozomu, Boku, Narikazu, Yamazaki, Kentaro, Koizumi, Wasaburo, Shimada, Ken, Takinishi, Yasutaka, Ohtsu, Atsushi
Publicado no Invest New Drugs (2015)

Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey(†)

Por Shiozawa, Tomoo, Tadokoro, Jun-ichi, Fujiki, Toshitaka, Fujino, Koji, Kakihata, Koji, Masatani, Shuji, Morita, Satoshi, Gemma, Akihiko, Boku, Narikazu
Publicado em 2013

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer

Por Suzuki, Eiichiro, Ikeda, Masafumi, Okusaka, Takuji, Nakamori, Shoji, Ohkawa, Shinichi, Nagakawa, Tatsuya, Boku, Narikazu, Yanagimoto, Hiroaki, Sato, Tosiya, Furuse, Junji
Publicado em 2013

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer

Por Yoshino, Takayuki, Yamazaki, Kentaro, Yamaguchi, Kensei, Doi, Toshihiko, Boku, Narikazu, Machida, Nozomu, Onozawa, Yusuke, Asayama, Masako, Fujino, Tadahiro, Ohtsu, Atsushi
Publicado em 2012

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Onozawa, Yusuke, Fuse, Nozomu, Yoshino, Takayuki, Yamazaki, Kentaro, Watanabe, Junichiro, Akimov, Mikhail, Robson, Matthew, Boku, Narikazu, Ohtsu, Atsushi
Publicado em 2014

Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer

Por Doi, Toshihiko, Boku, Narikazu, Kato, Ken, Komatsu, Yoshito, Yamaguchi, Kensei, Muro, Kei, Hamamoto, Yasuo, Sato, Atsushi, Koizumi, Wasaburo, Mizunuma, Nobuyuki, Takiuchi, Hiroya
Publicado em 2010

Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospecti...

Por TSUDA, TAKASHI, KYOMORI, CHISATO, MIZUKAMI, TAKURO, TANIYAMA, TOMOKO, IZAWA, NAOKI, HORIE, YOSHIKI, HIRAKAWA, MAMI, OGURA, TAKASHI, NAKAJIMA, TAKAKO EGUCHI, TSUGAWA, KOICHIRO, BOKU, NARIKAZU
Publicado no Mol Clin Oncol (2016)

Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?

Por Ishiki, Hiroto, Onozawa, Yusuke, Kojima, Takashi, Hironaka, Shuichi, Fukutomi, Akira, Yasui, Hirofumi, Yamazaki, Kentaro, Taku, Keisei, Machida, Nozomu, Boku, Narikazu, Hashimoto, Takayuki, Nishimura, Tetsuo
Publicado em 2012

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tum...

Por Murakami, Haruyasu, Doi, Toshihiko, Yamamoto, Nobuyuki, Watanabe, Junichiro, Boku, Narikazu, Fuse, Nozomu, Yoshino, Takayuki, Ohtsu, Atsushi, Otani, Satoru, Shibayama, Kazuhiro, Takubo, Takatoshi, Loh, Elwyn
Publicado em 2012

Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy

Por Tsushima, Takahiro, Taguri, Masataka, Honma, Yoshitaka, Takahashi, Hideaki, Ueda, Shinya, Nishina, Tomohiro, Kawai, Hiroki, Kato, Shunsuke, Suenaga, Mitsukuni, Tamura, Fumio, Morita, Satoshi, Boku, Narikazu
Publicado em 2012

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients(†)

Por Boku, Narikazu, Sugihara, Kenichi, Kitagawa, Yuko, Hatake, Kiyohiko, Gemma, Akihiko, Yamazaki, Naoya, Muro, Kei, Hamaguchi, Tetsuya, Yoshino, Takayuki, Yana, Ikuo, Ueno, Hiroshi, Ohtsu, Atsushi
Publicado em 2014

Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III tr...

Por Ioka, Tatsuya, Okusaka, Takuji, Ohkawa, Shinichi, Boku, Narikazu, Sawaki, Akira, Fujii, Yosuke, Kamei, Yoichi, Takahashi, Satori, Namazu, Katsushi, Umeyama, Yoshiko, Bycott, Paul, Furuse, Junji
Publicado no Jpn J Clin Oncol (2015)

Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system

Por Yamaguchi, Tomohiro, Machida, Nozomu, Morizane, Chigusa, Kasuga, Akiyoshi, Takahashi, Hideaki, Sudo, Kentaro, Nishina, Tomohiro, Tobimatsu, Kazutoshi, Ishido, Kenji, Furuse, Junji, Boku, Narikazu, Okusaka, Takuji
Publicado no Cancer Sci (2014)

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

Por Tahara, Makoto, Fuse, Nozomu, Mizusawa, Junki, Sato, Akihiro, Nihei, Keiji, Kanato, Keisuke, Kato, Ken, Yamazaki, Kentaro, Muro, Kei, Takaishi, Hiromasa, Boku, Narikazu, Ohtsu, Atsushi
Publicado no Cancer Sci (2015)

Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kina...

Por Takahashi, Toshiaki, Boku, Narikazu, Murakami, Haruyasu, Naito, Tateaki, Tsuya, Asuka, Nakamura, Yukiko, Ono, Akira, Machida, Nozomu, Yamazaki, Kentaro, Watanabe, Junichiro, Ruiz-Garcia, Ana, Imai, Keiji, Ohki, Emiko, Yamamoto, Nobuyuki
Publicado em 2012